<< Read Full Article
<< Read Full Article
Updated from 1:56 p.m. EDT
The health care sector mirrored the mixed nature of the major indices Wednesday, as positive clinical data boosted biotech names while earnings fears sank big pharmaceutical stocks.
Avanir Pharmaceuticals (AVNR Quote) was the day's best performer. The stock soared 308.7% after the company's Zenvia drug showed positive results in a Phase III clinical trial when used as treatment for diabetic neuropathic pain. Shares of Avanir were up $3.92 at $5.19.
Shares of Introgen Therapeutics (INGN Quote) also surged after the company late Tuesday announced positive early phase results for INGN 401, its proposed treatment for lung cancer. Introgen added 38 cents, or 7.4%, to $5.54. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,305.16 | 1,090.63 | 2,132.15 | 32.03 |
Oil *
78.45
|
|
DOWN
4.76
|
DOWN
0.86
|
DOWN
6.29
|
DOWN
0.28
|
10 Yr
3.20%
SPDR Gold
115.41
|
|
-0.05%
|
-0.08%
|
-0.29%
|
-0.87%
|
Data delayed 20 minutes |
Connect with TheStreet